Key result
Advanced cardiac imaging enables early detection and monitoring of cardiotoxicity in cancer patients.
Why the study?
Cardiac involvement in cancer is increasingly important, requiring multimodal imaging to assess direct cardiac involvement from disease progression and evaluate cardiovascular risk and cardiotoxicity from oncological therapies.
Multimodal cardiovascular imaging is essential for the early detection of cardiotoxicity and assessment of cardiac involvement in patients with extracardiac tumors.
Answers are grounded in this paper and cite their sources.
Supports multimodal imaging in cardio-oncology; leaves open prospective validation before practice change.
Cardiac involvement in cancer is increasingly important in the diagnosis and follow-up of patients. A thorough cardiovascular evaluation using multimodal imaging is crucial to assess any direct cardiac involvement from oncological disease progression and to determine the cardiovascular risk of patients undergoing oncological therapies. Early detection of cardiac dysfunction, particularly due to cardiotoxicity from chemotherapy or radiotherapy, is essential to establish the disease's overall prognostic impact. Comprehensive cardiovascular imaging should be integral to the clinical management of cancer patients. Echocardiography remains highly effective for assessing cardiac function, including systolic performance and ventricular filling pressures, with speckle-tracking echocardiography offering early insights into chemotoxicity-related myocardial damage. Cardiac computed tomography (CT) provides precise anatomical detail, especially for cardiac involvement due to metastasis or adjacent mediastinal or lung tumors. Coronary assessment is also important for initial risk stratification and monitoring potential coronary artery disease progression after radiotherapy or chemotherapeutic treatment. Finally, cardiac magnetic resonance (CMR) is the gold standard for myocardial tissue characterization, aiding in the differential diagnosis of cardiac masses. CMR's mapping techniques allow for early detection of myocardial inflammation caused by cardiotoxicity. This review explores the applicability of echocardiography, cardiac CT, and CMR in cancer patients with extracardiac tumors.
No takes yet. Share an insight, caveat, or question.
Tavernese et al. (2024) conducted a review in Cardiovascular complications in patients with extracardiac tumors. Advanced cardiac imaging (echocardiography, cardiac CT, CMR) was evaluated. Advanced cardiac imaging, including echocardiography, cardiac CT, and CMR, is crucial for the early detection and monitoring of cardiovascular complications and cardiotoxicity in cancer patients.
Synapse has enriched 10 related papers. Consider them for comparative context: